Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP
| Report ID | 264458 |
| Drug Identification Number | 02401029 |
| Brand name | CEFAZOLIN FOR INJECTION, USP |
| Common or Proper name | CEFAZOLIN FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFAZOLIN |
| Strength(s) | 100G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 g |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-08-01 |
| Actual start date | 2025-08-31 |
| Estimated end date | 2025-11-12 |
| Actual end date | 2025-11-11 |
| Shortage status | Resolved |
| Updated date | 2025-11-11 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Cefazolin for Injection, USP 100 g, SmartPak® Pharmacy Bulk Package, effective August 1, 2025, until October 24, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-11-11 | French | Compare |
| v9 | 2025-11-11 | English | Compare |
| v8 | 2025-10-17 | French | Compare |
| v7 | 2025-10-17 | English | Compare |
| v6 | 2025-09-30 | French | Compare |
| v5 | 2025-09-30 | English | Compare |
| v4 | 2025-09-23 | French | Compare |
| v3 | 2025-09-23 | English | Compare |
| v2 | 2025-08-06 | French | Compare |
| v1 | 2025-08-06 | English | Compare |
Showing 1 to 10 of 10